New treatment option for Cancer, Breast
Official title With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
ClinicalTrials.gov ID: NCT05721976
What this study is testing
- What it's testing
- The purpose of this study is to assess the feasibility, acceptability, and preliminary effects of a digital (web and mobile-phone-based) program to improve lifestyle behaviors (physical activity, dietary intake) among Hispanic female cancer survivors and adult daughters.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older, women only
You may be able to join if
- Cancer Survivor
- Grandmother
- Self-identifies as Hispanic
- Diagnosis of breast cancer (stages I-III), endometrial or ovarian cancer (stages I-II)
- Completed active treatment (i.e., surgery, chemotherapy, and/or radiation)
You likely can't join if
- Has been diagnosed with distant metastatic cancer
- Has not completed active treatment (i.e., surgery, chemotherapy, and/or radiation)
- Has uncontrolled schizophrenia or bipolar disorder
- Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions,wheelchair bound). Cancer...
- Has uncontrolled schizophrenia or bipolar disorder
- Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions, wheelchair bound)
See the full eligibility criteria
- Cancer Survivor
- Grandmother
- Self-identifies as Hispanic
- Diagnosis of breast cancer (stages I-III), endometrial or ovarian cancer (stages I-II)
- Completed active treatment (i.e., surgery, chemotherapy, and/or radiation)
- Body Mass Index (BMI) ≥ 25 (overweight range)
- Engages in \<150 minutes/week of moderate physical activity
- English or Spanish speaking
- Owns a mobile device with internet access (e.g., smartphone, tablet)
- Lives in South Florida Daughter of Cancer Survivor
- Adult daughter of the identified cancer survivor (21 years of age or older)
- Has at least 1 living child ages ≤16 years old
- Body Mass Index (BMI) ≥ 25 (overweight range) OR engages in \<150 minutes/week of moderate physical activity
- English or Spanish speaking
- Owns a mobile device with internet access (e.g., smartphone, tablet)
- Lives in South Florida Daughter of Cancer Survivor
- Has been diagnosed with distant metastatic cancer
- Has not completed active treatment (i.e., surgery, chemotherapy, and/or radiation)
- Has uncontrolled schizophrenia or bipolar disorder
- Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions,wheelchair bound). Cancer Survivor Exclusion Criteria:
- Has uncontrolled schizophrenia or bipolar disorder
- Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions, wheelchair bound)
The study team makes the final eligibility decision.
Where it's taking place
- Miami, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.